Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$36.71 - $44.15 $1.35 Million - $1.63 Million
-36,878 Reduced 24.6%
113,033 $4.7 Million
Q1 2023

May 12, 2023

BUY
$36.81 - $48.12 $1.59 Million - $2.07 Million
43,110 Added 40.36%
149,911 $6.19 Million
Q4 2022

Feb 13, 2023

SELL
$35.68 - $44.71 $1.59 Million - $2 Million
-44,646 Reduced 29.48%
106,801 $4.4 Million
Q3 2022

Nov 14, 2022

SELL
$42.51 - $54.02 $845,183 - $1.07 Million
-19,882 Reduced 11.6%
151,447 $6.63 Million
Q2 2022

Aug 15, 2022

BUY
$46.84 - $59.75 $546,763 - $697,461
11,673 Added 7.31%
171,329 $8.42 Million
Q1 2022

May 16, 2022

SELL
$48.09 - $57.79 $345,141 - $414,758
-7,177 Reduced 4.3%
159,656 $9.05 Million
Q4 2021

Feb 11, 2022

SELL
$47.19 - $62.68 $177 Million - $236 Million
-3,758,645 Reduced 95.75%
166,833 $8.76 Million
Q3 2021

Nov 15, 2021

SELL
$56.91 - $67.81 $93.4 Million - $111 Million
-1,641,255 Reduced 29.48%
3,925,478 $235 Million
Q2 2021

Aug 16, 2021

SELL
$64.02 - $71.72 $9.75 Million - $10.9 Million
-152,268 Reduced 2.66%
5,566,733 $377 Million
Q1 2021

May 17, 2021

SELL
$53.26 - $68.08 $30.6 Million - $39.1 Million
-574,406 Reduced 9.13%
5,719,001 $375 Million
Q4 2020

Feb 12, 2021

SELL
$43.41 - $56.51 $4.19 Million - $5.46 Million
-96,581 Reduced 1.51%
6,293,407 $355 Million
Q3 2020

Nov 16, 2020

BUY
$47.43 - $60.75 $20.4 Million - $26.1 Million
429,331 Added 7.2%
6,389,988 $310 Million
Q2 2020

Aug 14, 2020

BUY
$43.51 - $66.59 $9.86 Million - $15.1 Million
226,548 Added 3.95%
5,960,657 $332 Million
Q1 2020

May 14, 2020

SELL
$32.82 - $81.13 $9.72 Million - $24 Million
-296,220 Reduced 4.91%
5,734,109 $290 Million
Q4 2019

Feb 11, 2020

BUY
$60.96 - $77.7 $368 Million - $469 Million
6,030,329 New
6,030,329 $466 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.